Clinically useful tumor fluorescence greater than 24 hours after 5-aminolevulinic acid administration

BACKGROUND: 5-aminolevulinic acid (5-ALA) is a valuable surgical adjuvant used for the resection of glioblastoma multiforme (GBM). Since Food and Drug Administration approval in 2017, 5-ALA has been used in over 37,000 cases. The current recommendation for peak efficacy and intraoperative fluorescen...

Descripción completa

Detalles Bibliográficos
Autores principales: Haider, Sameah, Hamilton, Travis Matthew, Hunt, Rachel J., Lee, Ian Y., Robin, Adam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986640/
https://www.ncbi.nlm.nih.gov/pubmed/35399905
http://dx.doi.org/10.25259/SNI_836_2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986640/
https://www.ncbi.nlm.nih.gov/pubmed/35399905
http://dx.doi.org/10.25259/SNI_836_2021

Ejemplares similares